A PROLIFERATION OF NEW DATA SOURCES AND SOPHISTICATED ANALYTIC METHODS ARE HELPING RESEARCHERS TRANSFORM REAL-WORLD DATA (RWD) INTO REAL-WORLD EVIDENCE (RWE) TO ADDRESS IMPORTANT HEALTHCARE QUESTIONS. REGULATORS AND POLICYMAKERS RECOGNIZE THE POWER OF POLICY TO REALIZE THE FULL POTENTIAL OF DATA TO IMPROVE PATIENT CARE AND OUTCOMES. THE RWE ALLIANCE COMMENTS ON THE FDA DRAFT GUIDANCE POLICIES AND PROVIDES RECOMMENDATIONS TO THE FDA BEFORE THEY ISSUE FINAL GUIDANCE PROCEDURES ON VARIOUS ISSUES.